ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    Outcomes Associated with Carbapenem-Resistant Enterobacteriaceae Infection After Solid Organ Transplantation in a Multicenter Study.

    S. Huprikar,1 L. Casner,1 L. Camera Pierrotti,2 A. Nellore,3 R. Madan,4 J. Garcia-Diaz,5 S. Jacobs,6 D. Lee,7 W. Trindade Clemente,8 G. Alangaden,9 R. La Hoz,10 N. Theodoropoulos,11 M. Miceli,12 G. Santoro-Lopes,13 D. Banach,14 D. Simon,15 G. Patel.1

    1Mount Sinai, New York; 2Univ of Sao Paulo, Sao Paulo, Brazil; 3UAB, Birmingham; 4Albert Einstein, Bronx; 5Oschner, New Orleans; 6Cornell, New York; 7Drexel, Philadelphia; 8Univ Federal de Minas Gerais, Belo Horizonte, Brazil; 9Henry Ford, Detroit; 10UT Southwestern, Dallas; 11Ohio State, Columbus; 12U of Michigan, Ann Arbor; 13Federal Univ of Rio de Janeiro, Rio de Janeiro, Brazil; 14Yale, New Haven; 15Rush, Chicago.

    BackgroundCarbapenem-resistant Enterobacteriaceae infection (CREI) is associated with poor outcomes in solid organ transplant (SOT) recipients but most reports are single center experiences.MethodsPatients who underwent SOT…
  • 2016 American Transplant Congress

    Rituximab Induction in Cardiac Transplantation Is Associated with Accelerated Coronary Artery Vasculopathy: CTOT11.

    A. Chandraker, J. Kobashigawa, J. Stehlik, M. Givertz, R. Pierson, S. Pinney, M. Joren, S. Nissen, I. Guleria, Y. Morrison, B. Armstrong, N. Bridges, M. Sayegh, R. Starling.

    On Behalf of the CTOT11 Consortium, Brigham & Women's Hospital, Boston, MA.

    PurposeThe NIH-funded study CTOT11: Prevention of Cardiac Allograft Vasculopathy Using Rituximab (RIT) Therapy in Cardiac Transplantation, was a randomized clinical trial in non-sensitized primary heart…
  • 2015 American Transplant Congress

    Differential Role of PI3K Subunits Gamma and Delta in Regulatory T Cells Homeostasis in Allotransplantation

    J. Azzi, M. Uehara, Z. Solhjou, P. Lukyanchykov, A. Radwan, L. Riella, R. Abdi.

    Renal/Transplant Research Center, Brigham and Women's Hospital, Boston, MA.

    Targeting survival pathways that differentially suppress effector T cells (Teff) while sparing regulatory T cells (Tregs) is key in devising novel tolerogenic protocols in transplantation.…
  • 2015 American Transplant Congress

    Immune Reconstitution in Recipients of Living Donor Kidney/Hematopoietic Stem + Facilitating Cell Transplants

    J. Leventhal,1 M. Elliott,2 E. Yolcu,2 L. Bozulic,3 D. Tollerud,3 J. Mathew,1 I. Konieczna,1 M. Ison,1 M. Badder,3 M. Abecassis,1 J. Miller,1 L. Gallon,1 S. Ildstad.3

    1Comprehensive Transplant Center, Northwestern Memorial Hospital, Chicago, IL; 2University of Louisville, Institute for Cellular Therapeutics, Louisville, KY; 3Regenerex, LLC, Louisville, KY.

    We report the long-term results from a reduced-intensity nonmyeloablative conditioning approach to establish high levels of donor chimerism without graft-versus-host disease (GVHD) in mismatched related…
  • 2015 American Transplant Congress

    A Novel, Blocking Anti-CD40 Monoclonal Antibody Prolongs Non-Human Primate Renal Allograft Survival in the Absence of B-Cell Depletion Or Thromboembolic Events

    J. Rush,1 G. Wieczorek,1 M. Audet,2 M. Schneider,1 P. Espie,3 L. Roth,1 C. Heusser,1 C. Bruns,1 D. Patel,1 F. Cordoba.1

    1Autoimmunity, Transplantation and Inflammation, Novartis Institutes for Biomedical Research, Basel, Switzerland; 2Hôpital de Hautepierre, Strasbourg, France; 3Drug Metabolism and Pharmacokinetics, Novartis Institutes for Biomedical Research, Basel, Switzerland.

    Background. CD40-CD154 pathway blockade prolongs renal allograft survival in non-human primates (NHPs). However, antibodies targeting CD154 were associated with an increased incidence of thromboembolic complications…
  • 2015 American Transplant Congress

    Why Are Pancreas Transplant Volumes Declining?

    R. Carrico,1 J. Fridell,2 J. Odorico,3 H. Yeh,4 K. Tyler,1 S. Niederhaus.5

    1UNOS, Richmond, VA; 2Indiana Univ School of Medicine, Indianapolis, IN; 3Univ Wisconsin Hospital and Clinics, Madison, WI; 4Massachusetts General Hospital, Boston, MA; 5Univ of Maryland Medical System, Baltimore, MD.

    Background: Pancreas transplant volumes have been decreasing in the US since the mid-2000s. It has been conjectured that poor utilization of deceased donor pancreata (as…
  • 2015 American Transplant Congress

    Is BMI of 28 an Appropriate Cutoff for Simultaneous Pancreas Kidney Transplant in Type II Diabetes?

    E. Ahmed, D. Bruce, I. Carmody, A. Cohen, G. Loss, T. Reichman, J. Seal, H. Bohorquez.

    Multi-Organ Transplant Institute, Ochsner Clinic Foundation, New Orleans, LA.

    In simultaneous pancreas and kidney (SPK) transplantation, obesity has been reported to be associated with inferior survival and increased post-transplant complications. With implementation of the…
  • 2015 American Transplant Congress

    Controlled DCD Pancreas Transplantation : A Single Centre Experience

    M. Voskuil, S. Mittal, A. Muthusamy, J. Gilbert, S. Sinha, I. Quiroga, S. Reddy, P. Friend, E. Sharples, A. Vaidya, R. Ploeg.

    Oxford Transplant Centre, Oxford University, Oxford, United Kingdom.

    Background: The use of DCD pancreata are gaining popularity in the UK. Isolated pancreas transplantation (IP) is known to have inferior outcomes in comparison to…
  • 2015 American Transplant Congress

    Invasive CMV-Infection of the Duodenal Cuff – An Underestimated Entity of CMV Infection and Its Potential Impact On Outcome After Pancreas Transplantation

    A. Biglarnia,1 B. von Zur-Mühlen,1 S. Yamamoto,1 D. Berglund,1 M. Wagner,2 A. Sedigh,1 G. Tufveson,1 E. Larsson,3 F. Sund.2

    1Transplantation, Surgical Sciences, Uppsala, Sweden; 2Medical Scinces, Upsala, Sweden; 3Genetics and Pathology, Uppsala, Sweden.

    IntroductionWe present data on the incidence of focal invasive CMV-infection of the duodenal cuff and its potential impact on clinical outcome after pancreas transplantation (PT).Material…
  • 2015 American Transplant Congress

    Enhanced Production of Macrophage Chemoattractant Protein-1 (MCP-1) Within the Kidney in Brain Death Donors Predicts Recipient Allograft Function

    J. Chen, S. Antipenko, A. Zmijewska, R. Reed, J. Locke, R. Mannon.

    Medicine/Surgery, University of Alabama at Birmingham, Birmingham, AL.

    Brain death (BD) induces an intense pro-inflammatory state, which may impact recipient immunity and graft function after kidney transplantation. The identification of biomarkers predictive of…
  • « Previous Page
  • 1
  • …
  • 1334
  • 1335
  • 1336
  • 1337
  • 1338
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences